Compounding pharmacists from across America will be on Capitol Hill in Washington, D.C. next Tuesday, May 21 to ask Congress to act to preserve patient access to compounded medications. You can help tee-up our conversations with members of Congress by sending a message to your members of Congress NOW.
Help us preserve your access to compounded medications!
Reach out to your members of Congress THIS WEEK.
Compounding pharmacists from across America will be on Capitol Hill in Washington, D.C. next Tuesday, May 21 to ask Congress to act to preserve patient access to compounded medications. You can help tee-up our conversations with members of Congress by sending a message to your members of Congress NOW.
The “National Academies of Sciences, Engineering and Medicine Health and Medicine Division” has announced1 an investigation titled Clinical Utility of Treating Patients with Compounded “Bioidentical Hormone Replacement Therapy”. The fact that this written title describing the investigation has quotation marks only around “Bioidentical Hormone Replacement Therapy” gives us a very large clue that from the start this investigation will be biased, as it can’t bring itself to fully recognize the name that has been used by physicians and the millions of individuals using this treatment since the 1980s.
PCCA members will be in D.C., April 9-10, for the 7th Annual ACT Legislative Conference, calling on lawmakers to support patient access to compounded medications. If you can’t join us at ACT, we need your help in contacting your Representatives now on these 2 opportunities to help patients. Please review the following information and contact your Congressional Representatives’ offices now.
On March 20th, the AANP filed a Citizen’s Petition with the FDA as the next step in challenging the FDA’s unprecedented attack on physician-prescribed compounded nutrients which is on track to reject fully 95 percent of the 300+ nominated natural ingredients often used by patients as compounded medications.
We use cookies to optimize our website and our service.
Functional cookies Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.